Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019419708> ?p ?o ?g. }
- W2019419708 endingPage "2220" @default.
- W2019419708 startingPage "2206" @default.
- W2019419708 abstract "Many types of tumor, including glioma, melanoma, non-small cell lung, esophageal, and head and neck cancer, among others, are intrinsically resistant to apoptosis induction and poorly responsive to current therapies with proapoptotic agents. In addition, tumors often develop multidrug resistance based on the cellular efflux of chemotherapeutic agents. Thus, novel anticancer agents capable of overcoming these intrinsic or developed tumor resistance mechanisms are urgently needed. We describe a series of 2-aryl-2-(3-indolyl)acetohydroxamic acids that are active against apoptosis- and multidrug-resistant cancer cells as well as glioblastoma neurosphere stemlike cell cultures derived from patients. Thus, the described compounds serve as a novel chemical scaffold for the development of potentially highly effective clinical cancer drugs." @default.
- W2019419708 created "2016-06-24" @default.
- W2019419708 creator A5009000319 @default.
- W2019419708 creator A5014461472 @default.
- W2019419708 creator A5024545053 @default.
- W2019419708 creator A5033613763 @default.
- W2019419708 creator A5038404681 @default.
- W2019419708 creator A5050157691 @default.
- W2019419708 creator A5050210411 @default.
- W2019419708 creator A5053078484 @default.
- W2019419708 creator A5053342008 @default.
- W2019419708 creator A5058939223 @default.
- W2019419708 creator A5060584398 @default.
- W2019419708 creator A5064001520 @default.
- W2019419708 creator A5065805162 @default.
- W2019419708 creator A5068373986 @default.
- W2019419708 creator A5070771908 @default.
- W2019419708 creator A5076658405 @default.
- W2019419708 creator A5078472263 @default.
- W2019419708 creator A5078916422 @default.
- W2019419708 creator A5079014525 @default.
- W2019419708 creator A5083922162 @default.
- W2019419708 creator A5003077867 @default.
- W2019419708 date "2015-02-20" @default.
- W2019419708 modified "2023-10-07" @default.
- W2019419708 title "Activity of 2-Aryl-2-(3-indolyl)acetohydroxamates against Drug-Resistant Cancer Cells" @default.
- W2019419708 cites W1516339906 @default.
- W2019419708 cites W1924300297 @default.
- W2019419708 cites W1964738974 @default.
- W2019419708 cites W1967578658 @default.
- W2019419708 cites W1969909442 @default.
- W2019419708 cites W1971967721 @default.
- W2019419708 cites W1972940377 @default.
- W2019419708 cites W1978918505 @default.
- W2019419708 cites W1988255127 @default.
- W2019419708 cites W1990337776 @default.
- W2019419708 cites W1990519098 @default.
- W2019419708 cites W1998746732 @default.
- W2019419708 cites W2001544973 @default.
- W2019419708 cites W2006434892 @default.
- W2019419708 cites W2015610520 @default.
- W2019419708 cites W2018607339 @default.
- W2019419708 cites W2018671779 @default.
- W2019419708 cites W2025729195 @default.
- W2019419708 cites W2033987226 @default.
- W2019419708 cites W2034328391 @default.
- W2019419708 cites W2035021866 @default.
- W2019419708 cites W2041294276 @default.
- W2019419708 cites W2041843639 @default.
- W2019419708 cites W2044060877 @default.
- W2019419708 cites W2044878334 @default.
- W2019419708 cites W2048542407 @default.
- W2019419708 cites W2050522615 @default.
- W2019419708 cites W2051917121 @default.
- W2019419708 cites W2052887007 @default.
- W2019419708 cites W2060551076 @default.
- W2019419708 cites W2063095520 @default.
- W2019419708 cites W2066300890 @default.
- W2019419708 cites W2071551353 @default.
- W2019419708 cites W2083479805 @default.
- W2019419708 cites W2084479512 @default.
- W2019419708 cites W2087748260 @default.
- W2019419708 cites W2088246394 @default.
- W2019419708 cites W2088288204 @default.
- W2019419708 cites W2093216189 @default.
- W2019419708 cites W2102382046 @default.
- W2019419708 cites W2105287398 @default.
- W2019419708 cites W2114768416 @default.
- W2019419708 cites W2114918609 @default.
- W2019419708 cites W2116930406 @default.
- W2019419708 cites W2120350646 @default.
- W2019419708 cites W2124078079 @default.
- W2019419708 cites W2151342011 @default.
- W2019419708 cites W2158681922 @default.
- W2019419708 cites W2165871546 @default.
- W2019419708 cites W2167414381 @default.
- W2019419708 cites W2076197428 @default.
- W2019419708 doi "https://doi.org/10.1021/jm501518y" @default.
- W2019419708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4944210" @default.
- W2019419708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25671501" @default.
- W2019419708 hasPublicationYear "2015" @default.
- W2019419708 type Work @default.
- W2019419708 sameAs 2019419708 @default.
- W2019419708 citedByCount "44" @default.
- W2019419708 countsByYear W20194197082015 @default.
- W2019419708 countsByYear W20194197082016 @default.
- W2019419708 countsByYear W20194197082017 @default.
- W2019419708 countsByYear W20194197082018 @default.
- W2019419708 countsByYear W20194197082019 @default.
- W2019419708 countsByYear W20194197082020 @default.
- W2019419708 countsByYear W20194197082021 @default.
- W2019419708 countsByYear W20194197082022 @default.
- W2019419708 countsByYear W20194197082023 @default.
- W2019419708 crossrefType "journal-article" @default.
- W2019419708 hasAuthorship W2019419708A5003077867 @default.
- W2019419708 hasAuthorship W2019419708A5009000319 @default.
- W2019419708 hasAuthorship W2019419708A5014461472 @default.
- W2019419708 hasAuthorship W2019419708A5024545053 @default.